Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 5, 2015, Pages 520-523

  Hurford, Robert ^a,b   Rezvani, Sean ^a   Kreimei, Mohammad ^a   Herbert, Annie ^a,c   Vail, Andy ^a   Parry Jones, Adrian R ^a,b   Douglass, Chris ^b   Molloy, Jane ^b   Alachkar, Hana ^b   Tyrrell, Pippa J ^a,b   Smith, Craig J ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

AGED; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; LEFT HEMISPHERE; MAJOR CLINICAL STUDY; MALE; MOUTH EDEMA; OROLINGUAL ANGIOEDEMA; PREDICTION; PRIORITY JOURNAL; RESPIRATION CONTROL; RETROSPECTIVE STUDY; RIGHT HEMISPHERE; TREATMENT OUTCOME; TREATMENT PLANNING; ADVERSE EFFECTS; ANGIOEDEMA; CHEMICALLY INDUCED; COMPLICATION; FIBRINOLYTIC THERAPY; INCIDENCE; MOUTH; PATHOLOGY; RISK FACTOR; STROKE; TONGUE; UNITED KINGDOM;

AGED; ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ENGLAND; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; MALE; MOUTH; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TONGUE;

EID: 84927672465     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-308097     Document Type: Article

References (16)

1. Hill MD, Lye T, Moss H, et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 2003;60:1525-7.
2. Hill MD, Buchan AM. Canadian Alteplase for Stroke Effectiveness Study I. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005;172:1307-12.
3. Engelter ST, Fluri F, Buitrago-Tellez C, et al. Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol 2005;252:1167-70.
4. Yayan J. Lingual angioedema with macroglossia during the treatment of acute ischemic stroke with alteplase. Int J Gen Med 2012;5:183-6.
5. Yayan J. Onset of orolingual angioedema after treatment of acute brain ischemia with alteplase depends on the site of brain ischemia: a meta-analysis. N Am J Med Sci 2013;5:589-93.
6. Ottomeyer C, Sick C, Hennerici MG, et al. [Orolingual angioedema under systemic thrombolysis with rt-PA: an underestimated side effect]. Nervenarzt 2009;80:459-63.
7. Maertins M, Wold R, Swider M. Angioedema after administration of tPA for ischemic stroke: case report. Air Med J 2011;30:276-8.
8. Intercollegiate Stroke Working Party. National clinical guideline for stroke. 2012. http://www.rcplondon.ac.uk/resources/stroke-guidelines
9. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifi able subtypes of cerebral infarction. Lancet 1991;337: 1521-6.
10. National Institute of Health. National Institute of Neurological Disorders and Stroke Scale. 2014. http://www.ninds.nih.gov/disorders/stroke/pubs-stroke.htm
11. Molinaro G, Gervais N, Adam A. Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in vitro experimental approach. Stroke 2002;33:1712-16.
12. Cyr M, Lepage Y, Blais C Jr, et al. Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol 2001;281:H275-83.
13. th edn. Ottawa, Canada, 1999.
14. Groger M, Lebesgue D, Pruneau D, et al. Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2005;25:978-89.
15. Raidoo DM, Bhoola KD. Kinin receptors on human neurones. J Neuroimmunol 1997;77:39-44.
16. Hacke W, Kaste M, Bluhm E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.